Note: This is a plain-English reference, not legal advice, and does not create an attorney-client relationship. Consult a licensed attorney for guidance on your specific situation.

081 · Professional & Career Risk

Can I be fired for participating in a legal psilocybin program?

Last reviewed: August 29, 2026 · Psychedelic law changes quickly — verify current status before relying on this page.

Correction — August 29, 2026. An earlier edition of this article stated that ORS 659A.315 prohibits Oregon employers from disciplining employees for lawful off-duty psilocybin use. That was wrong. ORS 659A.315 concerns lawful tobacco products during nonworking hours and has nothing to do with psilocybin, and Oregon has no psilocybin employment protection of any kind. The article below has been rewritten to state the law correctly. The full record of this correction is in the corrections log.

For adults in Oregon who have accessed or are considering accessing the state’s licensed psilocybin program and want to understand whether their employer can take action against them for it.

The short answer

In most cases, yes. An Oregon employer may lawfully fire an employee over psilocybin use, including use that was entirely lawful under the state’s licensed program. Oregon is an at-will employment state, and no Oregon statute shields an employee from discipline for off-duty psilocybin use. ORS chapter 475A, which created and governs the licensed program, regulates licensees, service centers, facilitators, and clients — it contains no employment provision and imposes no obligation on employers at all. The disability-accommodation route that employees sometimes reach for is closed by statute where the employer acts on current illegal drug use, and psilocybin remains a Schedule I substance under federal law regardless of what Oregon permits. What protects most employees in practice is not a statute but a set of facts: standard drug panels do not detect psilocybin, most employers never learn a session happened, and an employer who does learn still has to decide whether it cares. That is a thin protection, and it is worth knowing exactly how thin before scheduling a session.

Oregon is at-will, with no psilocybin carve-out

Oregon employment is at will by default. Absent a contract, a collective bargaining agreement, civil service or just-cause protection, or a statute making a particular reason unlawful, an employer may end the relationship for a good reason, a bad reason, or no reason. The question in any wrongful-discharge analysis is therefore not whether the employer’s reason was fair. It is whether some specific source of law makes that reason unlawful.

For off-duty psilocybin use, no such source exists in Oregon. Measure 109 and the statutes that followed it are codified at ORS chapter 475A. That chapter builds an entire regulatory apparatus — licensing, product testing, service center standards, facilitator training, client confidentiality, taxation, local opt-outs — and at no point addresses the relationship between a client and the client’s employer. The only employment provision in the chapter is ORS 475A.489, a whistleblower protection: it shields employees of psilocybin licensees from retaliation for reporting suspected violations of the program’s own rules to the Oregon Health Authority. It says nothing about a client’s use of psilocybin, and it does not reach employers outside the licensed industry.

Oregon does have one statute limiting what an employer may forbid during nonworking hours. ORS 659A.315 makes it an unlawful employment practice to require, as a condition of employment, that an employee refrain from using lawful tobacco products during nonworking hours. It is a tobacco statute, it has not been substantively amended since 2005, and it has no application to psilocybin. Readers who have encountered a claim that this section protects psilocybin use — including in an earlier edition of this article — should discard it.

The disability-accommodation route, and where it stops

The most plausible legal theory available to an employee in this position runs through disability law rather than drug law. It is worth understanding both its shape and its limits, because the limits are where most cases end.

ORS 659A.112 makes it an unlawful employment practice to discriminate on the basis of disability, and it requires an employer to reasonably accommodate the known limitations of an otherwise qualified employee with a disability. The federal Americans with Disabilities Act does the same. But both carry an exclusion for current illegal drug use. ORS 659A.124(1) provides that the protections of ORS 659A.112 do not apply to an applicant or employee who is currently engaging in the illegal use of drugs if the employer takes action based on that conduct. Its federal counterpart, 42 U.S.C. § 12114(a), excludes from the definition of a qualified individual with a disability any employee who is currently engaging in the illegal use of drugs when the employer acts on the basis of that use.

Whether use that a state has authorized counts as “illegal” for this purpose is the exact question the Oregon Supreme Court answered in Emerald Steel Fabricators, Inc. v. Bureau of Labor and Industries, 348 Or 159 (2010). An employee holding a valid medical marijuana registry identification card was discharged for using marijuana. The court held that Oregon’s affirmative authorization of medical marijuana use was preempted by the federal Controlled Substances Act to the extent it authorized what federal law prohibits, and it held that under Oregon’s employment discrimination laws the employer was not required to accommodate the employee’s use of medical marijuana. A state license to use a federally scheduled substance did not convert that use into protected conduct.

Emerald Steel was a marijuana case, and no Oregon appellate court has yet applied it to psilocybin. But the reasoning transfers without strain. Psilocybin and psilocyn are Schedule I substances under 21 U.S.C. § 812, Oregon’s program affirmatively authorizes their use, and nothing in chapter 475A purports to alter their federal status. An employee who argues that ORS 659A.112 obliged the employer to accommodate a psilocybin session should expect the employer to cite Emerald Steel, and should expect that argument to carry.

What survives is narrower, but it is real. Disability law still protects the underlying condition. An employee with depression, PTSD, anxiety, or a substance use disorder remains entitled to accommodation of that condition — leave, schedule adjustment, modified duties — on the same terms as anyone else, and an employer that acts against the diagnosis rather than against the drug use has a genuine discrimination problem. The line is between accommodating the condition, which the law requires, and accommodating the psilocybin, which it does not.

Federal employers, contractors, and regulated industries

Where federal rules apply, the analysis is not close.

Federal employees are covered by Executive Order 12564, which recites that the use of illegal drugs by federal employees, on or off duty, is inconsistent with the trust placed in public servants, and directs agencies to establish drug-free workplace programs. A federal employee who accesses Oregon’s program is using a Schedule I substance and is exposed to agency discipline on that basis. See Could a security clearance, federal job, or professional license be affected by psychedelic use?.

Federal contractors holding contracts above the simplified acquisition threshold (41 U.S.C. § 8102) and federal grant recipients (41 U.S.C. § 8103) must agree to provide a drug-free workplace, publish a statement prohibiting the unlawful manufacture, distribution, possession, or use of a controlled substance in the workplace, and specify what will happen to employees who violate it. Those obligations run to the workplace rather than to off-duty conduct, but they routinely generate employer policies written broadly enough to reach both.

DOT-regulated safety-sensitive employees are tested under 49 CFR Part 40. The federally mandated panel at 49 CFR 40.85 covers marijuana metabolites, cocaine metabolite, codeine and morphine, hydrocodone and hydromorphone, oxycodone and oxymorphone, 6-acetylmorphine, phencyclidine, amphetamine and methamphetamine, and MDMA and MDA. Psilocybin is not on it. That is a fact about the federal test, not a permission — a DOT-regulated employer remains free to discipline under its own conduct rules.

A licensed session versus impairment at work

Two different things get discussed under one heading, and separating them resolves most of the practical questions.

The first is the conduct itself. Under ORS 475A.498, a client may purchase, possess, and consume a psilocybin product only at a licensed service center and only under the supervision of a licensed facilitator. Sessions are scheduled, supervised, and confined to licensed premises. They are not something that happens at work or on the way to work, and an employee who completes a session and goes home has violated no Oregon law.

The second is fitness for duty, and the first fact does no work on it. Acute psilocybin effects typically last six to eight hours, and residual effects — fatigue, altered perception, emotional openness — can persist into the following day. An employee who arrives unfit to perform is exposed on ordinary grounds that have nothing to do with psilocybin. In safety-sensitive work — healthcare, childcare, transportation, heavy equipment — the employer’s interest in fitness for duty is at its strongest and its tolerance for uncertainty at its narrowest. Leaving two to three days between a session and the next shift removes the exposure that matters most, and it is the single most useful step an employee can take.

Detection is a third and separate question. Standard employment panels, including the SAMHSA-5, do not include psilocybin or psilocin. Psilocin clears quickly — detectable in urine for roughly eight to twenty-four hours, and then only through a targeted assay that routine screening does not order. Most employees who access the program will never produce a psilocybin-related positive result. See Drug testing and psychedelics: what employers can and cannot do for the full testing framework. But an employer does not need a test result to act. Employers learn about sessions from voluntary disclosures, from social media, from colleagues, and from employees who assumed a legal protection that does not exist.

What an employer policy can and cannot do

An Oregon employer may write a drug-free workplace policy that prohibits the use of federally scheduled substances on or off duty, and may enforce it against an employee who accesses the licensed program. It may require fitness for duty, test where testing is otherwise lawful, and discipline for impairment. Because there is no state carve-out to violate, the “solely because of lawful off-duty use” framing that governs employment statutes in some other states has no application in Oregon.

What an employer cannot do is enforce such a policy in a way that breaks some other body of law. It cannot apply the policy selectively along lines ORS 659A.030 protects — race, color, religion, sex, sexual orientation, gender identity, national origin, marital status, age — and then point at the policy as its defense. It cannot use the policy as cover for acting against an underlying disability rather than against drug use. It cannot override a collective bargaining agreement’s just-cause provision, an individual employment contract, or the civil service and due-process protections attaching to many public positions. And it cannot compel a service center or facilitator to reveal that an employee was a client: ORS 475A.450 makes client-identifying information and client communications confidential, subject to enumerated exceptions that do not include employer inquiries. In practice, an employer’s route to that knowledge is the employee.

Practical steps before accessing the program

Read the policy before the session rather than after. The provisions that matter are the drug-free workplace policy, any conduct or fitness-for-duty standard, and any clause referencing federal law, federally scheduled substances, or participation in federally mandated testing. If the policy reaches federally scheduled substances, it reaches psilocybin.

Confirm whether the position is safety-sensitive under federal regulation. DOT, FAA, FMCSA, FRA, FTA, and PHMSA each define safety-sensitive categories carrying testing obligations that operate regardless of anything Oregon law provides.

Schedule conservatively — two to three days between a session and the next shift, rather than returning to work the following morning.

And weigh disclosure carefully. There is no legal advantage to telling an employer about a session in advance. No Oregon statute rewards candor here, and a disclosure hands the employer information it would otherwise not have. Whether to tell an employer is a personal decision rather than a legal one, but it should be made with the actual law in view rather than a supposed protection.

If adverse action has already occurred

There is no Oregon claim for being fired over lawful off-duty psilocybin use as such. But the reason an employer gives is not always the whole reason, and several claims can survive facts that look at first like a simple psilocybin discharge.

Disability discrimination, where the real basis was the underlying condition rather than the drug use. Discrimination on a protected class basis under ORS 659A.030, where a facially neutral policy was enforced selectively. Retaliation, where the discharge followed a protected report or complaint — including, for employees of psilocybin licensees, the whistleblower protection at ORS 475A.489. Breach of an employment contract, a collective bargaining agreement, or a public employer’s just-cause and due-process obligations. And unemployment insurance eligibility, which turns on whether the Employment Department finds disqualifying misconduct and is a separate question from whether the discharge was lawful.

Deadlines are short. A complaint to the Oregon Bureau of Labor and Industries under ORS 659A.820 must generally be filed within one year of the alleged unlawful practice, and the civil action deadlines in ORS 659A.875 are of the same order for most claims. An employee who thinks any of the above may apply should speak with an employment lawyer well before that year runs, and should preserve the written policy, the discipline record, and any communications about the reason for the action.

When public information may be enough

ORS chapter 475A and ORS 659A.030, 659A.112, 659A.124, 659A.820, and 659A.875 are published by the Oregon Legislative Assembly and free to read. Emerald Steel Fabricators, Inc. v. Bureau of Labor and Industries, 348 Or 159 (2010), is available through CourtListener. BOLI publishes general guidance on Oregon employment discrimination and on how to file a complaint at oregon.gov/boli; it does not publish guidance on psilocybin and employment, because there is no Oregon psilocybin employment statute for it to administer. Federal drug-free workplace requirements for contractors and grant recipients are at 41 U.S.C. §§ 8102–8103, federal employee drug policy at Executive Order 12564, DOT testing rules at 49 CFR Part 40, and the federal drug schedules at 21 U.S.C. § 812. An employee whose only question is whether Oregon law protects them can answer it from these sources: it does not.

When you should speak with a lawyer

Speak with an employment lawyer if adverse action has already occurred and any part of the picture involves a disability, a protected class, a prior complaint, a contract, or a union agreement. Those are the facts that turn an unprotected discharge into a claim, and they are easy to miss from the inside. Speak with one before a session if you hold a security clearance, work for a federal agency or federal contractor, hold a professional license, or occupy a DOT safety-sensitive position, because in those settings the consequences reach past the job itself. And speak with one if your employer has a policy you cannot read confidently — an ambiguous drug-free workplace clause is worth a single consultation, which costs a great deal less than a discharge.

You might also want to read

This article is for general informational purposes only and does not constitute legal advice. Employment law and drug testing requirements change and vary by industry and employer type. For advice specific to your employment situation, consult a licensed attorney.

Built by Aloha AI. Explore all AI tools and projects at RN Builds.